▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2288 by analyst upside · 2026-06-27
XRAY
DENTSPLY SIRONA Inc.
Healthcare · Market Cap $2B · P/E 0x
ANALYST PRICE TARGET
+21.7%
implied upside to consensus target
Current Price $11.01
Consensus Target $13.4
Bull Target $17.0
Bear Target $9.0
Analysts Covering 15
ANALYST CONSENSUS — HOLD
Strong Buy
2
Buy
2
Hold
11
Sell
0
52-Week Low $9.41
52-Week High $17.09
YTD Return -2.3%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) N/A
Forward P/E 7.1x
EPS (TTM) $-3.15
PEG Ratio 0.75
Dividend Yield 5.04%
Revenue (TTM) $3.7B
Profit Margin -17.1%
52-WEEK RANGE
52-Week Low $9.41
52-Week High $17.09
Current Price $11.01
Bear Target $9.0
Bull Target $17.0
● Now $11.01 ● Target $13.4
TRADING DATA
Avg Volume 4.8M
YTD Return -2.3%
Analyst Count 15
Consensus Hold
Upside to Target +21.7%
Last Updated 2026-06-27

ANALYST SUMMARY

DENTSPLY SIRONA Inc. (XRAY) is currently trading at $11.01 with a Wall Street consensus price target of $13.4, implying potential upside of 21.7% over the next 12 months. 15 analysts currently cover XRAY, with a consensus rating of Hold — 27% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $17.0, while the most cautious has a target of $9.0.

XRAY operates in the Healthcare sector with a market capitalisation of $2B. The stock is down 2.3% year-to-date and is currently trading near the lower end of its 52-week range of $9.41 – $17.09.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

PBH +35.2%
Prestige Consumer Healthcare Inc.
$2B · P/E 12.6x · Buy
SEM +0.8%
Select Medical Holdings Corporation
$2B · P/E 15.4x · Hold
UFPT +24.9%
UFP Technologies, Inc.
$2B · P/E 29.6x · Underperform
LMAT +24.1%
LeMaitre Vascular, Inc.
$2B · P/E 34.5x · Buy
ADUS +36.9%
Addus HomeCare Corporation
$2B · P/E 17.9x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for XRAY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays — Reiterated
Underweight → Underweight 2026-06-04 Building track record
UBS — Reiterated
Buy → Buy 2026-05-07 33% win rate (6 calls)
Mizuho — Reiterated
Neutral → Neutral 2026-05-06 Building track record
Citigroup ● Initiated
Sell 2026-04-15 Building track record
Mizuho — Reiterated
Neutral → Neutral 2026-03-02 Building track record
Barrington Research — Reiterated
Outperform → Outperform 2026-03-02 Building track record
Wells Fargo — Reiterated
Equal-Weight → Equal-Weight 2026-02-27 Building track record
Evercore ISI Group — Reiterated
In-Line → In-Line 2026-02-27 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
—
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →